News | February 17, 2025
Nectar Life Care launches affordable anti-diabetic range of medicines
Offers affordable, high-quality solutions for diabetes care
Offers affordable, high-quality solutions for diabetes care
During the quarter, US formulations revenue decreased by 2.3% YoY to Rs. 3,671 crore.
This collaboration aims to bridge modern scientific research with traditional Ayurvedic wisdom, fostering innovative solutions that support holistic well-being
Profit after Taxes registered strong growth of 22% to Rs. 162 crores versus Rs. 134 crores in Q3 FY24
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
The group reported Q3FY25 operating revenue of Rs 3,821 crore, driven by sustained double-digit growth of 14 per cent in biosimilars
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
Subscribe To Our Newsletter & Stay Updated
